Skip to main content
OpenTrials
Completed

NCT Number: NCT01180998

Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens Users

The purpose of this study is to evaluate the clinical performance, defined as successful fit, of two toric contact lenses (one daily disposable and the other daily wear reusable contact lens to correct astigmatism) in current spherical soft contact lens wearers, contact lens drop-outs, and non-users of toric contact lenses (neophytes).

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Reading, Berkshire, United Kingdom

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects must satisfy the following conditions prior to inclusion in the study:

  • One of the following:
  • Spherical contact lens user (minimum of 2 months wear, four days a week, 8 hours a day)
  • Contact Lens drop-out (no contact lens wear in the last 6 months but wearing glasses at least four days a week,8 hours a day)
  • Neophyte (no habitual contact lens wear except for trial fits up to 1 week, but wearing glasses at least four days a week,8 hours a day For patients not currently wearing lenses, patient should have expressed a desire to try lenses.
  • Between 16 and 60 years of age.
  • Have signed an informed consent form (documented by the investigator in the Case Report Form [CRF]).
  • Distance requirement in the range of +4.00D to -9.00D (i.e. -10.00D refractive)
  • Refractive astigmatism between -0.75D and -3.00D in both eyes.
  • Have best corrected VA of 6/9 (20/30) or better in each eye.
  • Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having:
  • No amblyopia.
  • No evidence of lid abnormality or infection.
  • No conjunctival abnormality or infection.
  • No clinically significant slit lamp findings (i.e. stromal haze, staining, scarring, vascularisation, infiltrates or abnormal opacities).
  • No other active ocular disease.
  • Presbyopes may be included (no monovision, no spectacles over contact lenses or bifocal glasses only)

Exclusion criteria

Any of the following will render a subject ineligible for inclusion:

  • Requires concurrent ocular medication.
  • Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperaemia, limbal hyperaemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Corneal staining Grade 3 in more than two regions.
  • Extended wear in the last 3 months.
  • Has had any anterior ocular surgery. Has had any other ocular surgery or injury within 8 weeks immediately prior to enrollment for this study.
  • Abnormal lachrymal secretions.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Keratoconus or other corneal irregularity.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Has diabetes.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • Pregnancy, lactating, or planning a pregnancy at the time of enrollment.
  • Participation in any concurrent clinical trial or in last 60 days.

Treatment and study plan

Senofilcon A Toric (AOfA)

Device

Soft toric contact lenses for astigmatism

Etafilcon A Toric (1DAMfA)

Device

Soft toric contact lenses for astigmatism

Primary outcomes

  1. Overall Success in Fitting With a Toric Contact Lens

    Time frame: 4 weeks

    Percent of subjects with success with toric lens fitting defined as meeting all of the following pre-determined criteria: 1) acceptable fit, 2) orientation stability less than or equal to 20 degree rotation, 3) binocular visual acuity (VA) within one line of spectacle VA, 4) Good, very good, or excellent overall quality of Vision, and 5) good, very, good, or excellent overall lens comfort. There was not an inferential statistical analysis conducted on this outcome. Comparison was made through the use of 95% CI's for the proportions. Therefore no statistical analysis section is included for this primary outcome.

  2. Distance Visual Acuity

    Time frame: after 1 week of toric contact lens wear

    Measured monocularly (each eye separately) in Snellen converted to logMAR units. The logMAR scale has a range of -0.30 to 1.00. A value of 0 or less would not require distance vision correction and a value of 0 or greater may require distance vision correction.

  3. Distance Visual Acuity (VA)

    Time frame: after 4 weeks of toric contact lens wear

    Visual Acuity is measured monocularly (each eye separately) in Snellen, the converted to logMAR units. The logMAR scale has a range of -0.30 to 1.00. A value of 0 or less would not require distance vision correction and a value of 0 or greater may require distance vision correction.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Vision Care, Inc.

Industry

Collaborators

  • Visioncare Research Ltd.

Registry information

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Aug 13, 2010
Registry last updated
Jun 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.